ESOMOWEL-LS contains Esomeprazole 40 mg + Levosulpiride 75 mg SR, offering complementary acid suppression and gastroprokinetic action for selected acid-related and motility-associated disorders. A differentiated PCD Pharma Gastro offering.
GERD, dyspepsia and reflux-related symptoms associated with impaired gastric motility.
To address acid secretion and motility together.
Take as prescribed, usually before food. Inform the physician about movement disorders, hormonal problems, cardiac issues or other medicines.
Headache, nausea, diarrhea, abdominal discomfort, dizziness and fatigue may occur.
ESOMOWEL-LS: Esomeprazole reduces gastric acid secretion, while Levosulpiride enhances gastrointestinal motility and supports coordinated gastric emptying.
